33187 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Sep 16
00:12 UTC
|
BLKB
Blackbaud
|
◎ Target | Rob Oliver not yet tracked | Outperform | $54.00→ $58.00+7.4% |
|
Sep 16
00:12 UTC
|
BKV
BKV
|
◎ Target | Betty Jiang ★★★☆☆ #1296 | Overweight | $36.00→ $35.00-2.8% |
|
Sep 16
00:12 UTC
|
BCE
BCE
|
◎ Target | firm only | Buy | C$37.00→ C$40.00+8.1% |
|
Sep 16
00:12 UTC
|
BBNX
Beta Bionics
|
◎ Target | Travis Steed ★★★★★ #299 | Neutral | $18.00→ $20.00+11.1% |
|
Sep 16
00:12 UTC
|
BBNX
Beta Bionics
|
◎ Target | Jeff Johnson ★★★☆☆ #1664 | Neutral | $14.00→ $16.00+14.3% |
|
Sep 16
00:12 UTC
|
BARC
Barclays
|
◎ Target | firm only | Overweight | GBX 610→ GBX 620+1.6% |
|
Sep 16
00:12 UTC
|
AZN
AstraZeneca
|
◎ Target | firm only | Buy | £160→ £150-6.2% |
|
Sep 16
00:12 UTC
|
AXR
AMREP
|
◎ Target | Zhiger Kurmet not yet tracked | Hold | $26.00→ $22.00-15.4% |
|
Sep 16
00:12 UTC
|
AU
AngloGold Ashanti
|
◎ Target | Patrick Jones ★★★☆☆ #1483 | Overweight | $134.00→ $140.00+4.5% |
|
Sep 16
00:12 UTC
|
AGF.B
AGF Management
|
◎ Target | firm only | Buy | C$24.00→ C$23.00-4.2% |
|
Sep 16
00:12 UTC
|
ABOS
Acumen Pharmaceuticals
|
◎ Target | Geoff Meacham ★★★☆☆ #1570 | Buy | $4.00→ $5.00+25.0% |
|
Sep 16
00:12 UTC
|
ULTA
Ulta Beauty
|
↓ Downgrade | Steven Zaccone ★★★☆☆ #1542 | Neutral→ Market Perform | |
|
Sep 16
00:12 UTC
|
ULTA
Ulta Beauty
|
↓ Downgrade | Olivia Tong ★☆☆☆☆ #3096 | Strong-Buy→ Outperform | |
|
Sep 16
00:12 UTC
|
SRRK
Scholar Rock
|
↓ Downgrade | Etzer Darout ★★★★☆ #595 | Overweight→ Cautious | |
|
Sep 16
00:12 UTC
|
IOCJY
Iochpe-Maxion
|
↓ Downgrade | firm only | Neutral | |
|
Sep 16
00:12 UTC
|
ET
Evertz Technologies
|
↓ Downgrade | firm only | Buy→ Hold | C$18.00→ C$15.00-16.7% |
|
Sep 16
00:12 UTC
|
DATA
GlobalData
|
↓ Downgrade | firm only | Buy | GBX 98→ GBX 170+73.5% |
|
Sep 16
00:12 UTC
|
BAK
Braskem
|
↓ Downgrade | firm only | Neutral→ Sell | $1.50 |
|
Sep 16
00:12 UTC
|
ASND
Ascendis Pharma A/S
|
↓ Downgrade | Martin Auster ★☆☆☆☆ #3131 | Strong-Buy→ Outperform | $287.00 |
|
Sep 16
00:12 UTC
|
ACVA
ACV Auctions
|
↓ Downgrade | Robert Labick not yet tracked | Market Outperform→ Market Perform | |
|
Sep 16
00:12 UTC
|
WFG
West Fraser Timber
|
↑ Upgrade | Daryl Swetlishoff ★★★☆☆ #1048 | Market Perform→ Outperform | $75.00→ $85.00+13.3% |
|
Sep 16
00:12 UTC
|
ULTA
Ulta Beauty
|
↑ Upgrade | firm only | Outperform | |
|
Sep 16
00:12 UTC
|
ULTA
Ulta Beauty
|
↑ Upgrade | firm only | Outperform | |
|
Sep 16
00:12 UTC
|
ULTA
Ulta Beauty
|
↑ Upgrade | Ike Boruchow ★★★☆☆ #1427 | Underweight→ Equal Weight | $450.00→ $525.00+16.7% |
|
Sep 16
00:12 UTC
|
TRP
TC Energy
|
↑ Upgrade | firm only | Hold→ Buy | C$102.00 |
|
Sep 16
00:12 UTC
|
THRM
Gentherm
|
↑ Upgrade | Rajat Gupta not yet tracked | Neutral→ Overweight | $48.00 |
|
Sep 16
00:12 UTC
|
SEIC
SEI Investments
|
↑ Upgrade | Jeff Schmitt ★★★★★ #160 | Market Perform→ Outperform | |
|
Sep 16
00:12 UTC
|
RMD
ResMed
|
↑ Upgrade | Craig Wong-Pan ★★★★☆ #710 | Sec→ r Perform ➝ Outperform | $244.00→ $262.00+7.4% |
|
Sep 16
00:12 UTC
|
RLGT
Radiant Logistics
|
↑ Upgrade | firm only | Market Perform→ Outperform | |
|
Sep 16
00:12 UTC
|
RLGT
Radiant Logistics
|
↑ Upgrade | Jeff Kauffman ★★★☆☆ #1729 | Market Perform→ Market Outperform | $10.00 |
|
Sep 16
00:12 UTC
|
REXR
Rexford Industrial Realty
|
↑ Upgrade | David Rodgers not yet tracked | Underperform→ Market Perform | |
|
Sep 16
00:12 UTC
|
QBR.B
Quebecor
|
↑ Upgrade | firm only | Market Perform→ Outperform | C$72.00→ C$75.00+4.2% |
|
Sep 16
00:12 UTC
|
PNR
Pentair
|
↑ Upgrade | Nigel Coe ★★☆☆☆ #2499 | Peer Perform→ Outperform | $91.00 |
|
Sep 16
00:12 UTC
|
NYT
New York Times
|
↑ Upgrade | Curry Baker ★★★☆☆ #1685 | Neutral→ Buy | $70.00→ $82.00+17.1% |
|
Sep 16
00:12 UTC
|
MIDD
Middleby
|
↑ Upgrade | Tami Zakaria ★★★★☆ #954 | Neutral→ Overweight | $141.00→ $147.00+4.3% |
|
Sep 16
00:12 UTC
|
LKNCY
Luckin Coffee
|
↑ Upgrade | firm only | Outperform | $48.00 |
|
Sep 16
00:12 UTC
|
IFP
Interfor
|
↑ Upgrade | firm only | Outperform→ Strong-Buy | C$17.00→ C$21.00+23.5% |
|
Sep 16
00:12 UTC
|
GSK
GSK
|
↑ Upgrade | Kerry Holford ★★★☆☆ #1373 | Hold→ Buy | |
|
Sep 16
00:12 UTC
|
EVPL
Everplay Group
|
↑ Upgrade | firm only | Buy | GBX 460 |
|
Sep 16
00:12 UTC
|
ETSY
Etsy
|
↑ Upgrade | Jason Helfstein ★★★☆☆ #2217 | Market Perform→ Outperform | $90.00 |
|
Sep 16
00:12 UTC
|
ENB
Enbridge
|
↑ Upgrade | firm only | Hold→ Buy | C$82.00→ C$81.00-1.2% |
|
Sep 16
00:12 UTC
|
ENB
Enbridge
|
↑ Upgrade | firm only | Sec→ r Perform ➝ Outperform | C$81.00→ C$82.00+1.2% |
|
Sep 16
00:12 UTC
|
ENB
Enbridge
|
↑ Upgrade | firm only | Market Perform→ Outperform | C$79.00→ C$79.50+0.6% |
|
Sep 16
00:12 UTC
|
ENB
Enbridge
|
↑ Upgrade | firm only | Sec→ r Perform ➝ Outperform | |
|
Sep 16
00:12 UTC
|
CRDF
Cardiff Oncology
|
↑ Upgrade | Robert Burns ★★★☆☆ #1867 | Neutral→ Buy | |
|
Sep 16
00:12 UTC
|
CFP
Canfor
|
↑ Upgrade | firm only | Outperform→ Strong-Buy | C$17.00→ C$21.00+23.5% |
|
Sep 16
00:12 UTC
|
BNTC
Benitec Biopharma
|
↑ Upgrade | firm only | Outperform | |
|
Sep 16
00:12 UTC
|
AZN
Astrazeneca
|
↑ Upgrade | firm only | Sell→ Hold | |
|
Sep 16
00:12 UTC
|
AGL
Agilon Health
|
↑ Upgrade | Lance Wilkes ★★★★★ #180 | Market Perform→ Outperform | $86.00→ $125.00+45.3% |
|
Sep 16
00:12 UTC
|
ADNT
Adient
|
↑ Upgrade | Rajat Gupta not yet tracked | Neutral→ Overweight | $28.00→ $25.00-10.7% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.